ELECTROMAGNETIC BIOLOGY AND MEDICINE, published by Taylor & Francis Inc, is a pioneering journal that delves into the intricate relationships between electromagnetic fields and biological systems. With an ISSN of 1536-8378 and an E-ISSN of 1536-8386, this esteemed publication has been serving the scientific community since its inception in 1982. As a vital resource in the fields of biophysics and medical sciences, it is categorized in the Q3 quartile for both Biophysics and Medicine (miscellaneous) as of 2023, reflecting its significant contributions and robust research output. With Scopus rankings indicating a 61st percentile in Medicine and a 44th percentile in Biophysics, this journal is instrumental for researchers, professionals, and students seeking to explore the multifaceted applications of electromagnetic phenomena in health and medicine. This journal offers access options tailored to enhance visibility and dissemination of research, emphasizing its commitment to advancing knowledge and fostering innovation in this interdisciplinary domain.

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

Physiology and Pharmacology is a distinguished open access journal that has been disseminating high-quality research in the fields of physiology and pharmacology since its inception in 1997. Published by the Iranian Society of Physiology & Pharmacology, this journal offers a platform for scholars and practitioners to share innovative findings and advancements that contribute to the understanding of biological systems and drug action. With its ISSN 2476-5236 and E-ISSN 2476-5244, it ensures global reach and accessibility. The journal is positioned in the third quartile for Linguistics and Language and fourth quartile in both Pharmacology and Physiology categories according to Scopus rankings, reflecting a commitment to expanding knowledge within these interdisciplinary domains. Set within the academic landscape of Iran, the journal aims to bridge regional research with the international community, providing valuable insights into physiological processes and pharmacological developments. In light of its open access model, the Physiology and Pharmacology journal plays a crucial role in enhancing the visibility of research outcomes and fostering collaboration among researchers, professionals, and students on a global scale.

Undersea and Hyperbaric Medicine is a pivotal journal published by the Undersea & Hyperbaric Medical Society Inc., focusing on the advanced field of undersea and hyperbaric medical research. It has served the scientific community since its inception in 1993, and is recognized for its commitment to disseminating peer-reviewed articles that address both the clinical and scientific aspects of hyperbaric medicine and related disciplines. The journal is indexed in various databases and classified in key quartiles, ranking Q3 in Medicine (miscellaneous) and Q4 in Physiology (medical) as of 2023, making it an essential resource for professionals engaged in these specialized areas. Although the journal does not currently offer open access, its implications and contributions to the fields of pulmonary and respiratory medicine and physiology are substantial, with a Scopus rank indicating its relevance despite some competitive challenges. This publication serves as a vital platform for researchers, allows for the exploration of novel therapies, and promotes the dissemination of knowledge critical for advancements in medical practice related to undersea and hyperbaric environments.

Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

Antioxidants is a premier open-access journal published by MDPI that has been actively contributing to the field of antioxidant research since its inception in 2012. Based in Switzerland, the journal holds a noteworthy impact factor indicative of its scholarly influence, particularly given its high rankings in various categories. As of 2023, it proudly sits in the Q1 quartile in Biochemistry, Clinical Biochemistry, Food Science, and Physiology, solidifying its status as a critical resource for innovative studies. With a strong focus on the roles of antioxidants across multiple disciplines—ranging from molecular biology to food science—this journal serves as a vital platform for researchers, professionals, and students aiming to advance knowledge in mitigating oxidative stress and enhancing health through dietary and therapeutic approaches. The open-access model guarantees wide accessibility, allowing for the dissemination of significant research findings globally, making it indispensable for anyone engaged in modern biochemical and physiological studies.

BioMedicine-Taiwan, published by DIGITAL COMMONS BEPRESS, stands as a prominent open-access journal that has been disseminating vital research since 2014. With an ISSN of 2211-8020 and E-ISSN 2211-8039, this journal covers a wide array of disciplines within the biomedical field, reaching researchers and professionals keen on exploring cutting-edge advancements and innovative approaches in biochemistry, genetics, and general medicine. Notably categorized as Q2 in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine for 2023, BioMedicine-Taiwan ranks well in its respective fields, reflecting its commitment to enhancing scholarly communication and knowledge dissemination. Situated in Taiwan, its impact is further highlighted by its Scopus rankings—placing it in the 70th percentile for general medicine and 47th percentile for general biochemistry and molecular biology, showcasing its significance in ongoing biomedical discourse. Researchers, students, and professionals are invited to engage with this invaluable resource to explore the latest findings and developments that shape the future of healthcare and biological sciences.

Photodiagnosis and Photodynamic Therapy is a leading journal published by Elsevier, specializing in the fields of biophysics, dermatology, oncology, and pharmacology. With an impressive Q2 ranking across multiple categories in the 2023 category quartiles, this journal is pivotal for researchers and practitioners aiming to advance their knowledge and expertise in photodiagnostic and therapeutic techniques. Since its inception in 2004, it has provided a critical platform for peer-reviewed articles exploring the latest advancements and applications in light-based treatments. As of 2024, the journal will be fully Open Access, enhancing its accessibility and reach across the scientific community. Located in Amsterdam, Netherlands, this journal's commitment to fostering innovation and collaboration makes it an essential resource for those interested in the intersection of light-based technologies and medicine. With its high visibility in key indexed databases like Scopus, researchers can trust that their contributions will be well-regarded and widely disseminated.

NITRIC OXIDE-BIOLOGY AND CHEMISTRY is a premier journal dedicated to the exploration of the multifaceted roles of nitric oxide in biological systems, contributing significantly to the fields of biochemistry, physiology, and cancer research. Published by Academic Press Inc, Elsevier Science, the journal boasts a solid reputation, evidenced by its 2023 quartile rankings, including Q2 in Biochemistry, Clinical Biochemistry, and Physiology, as well as Q3 in Cancer Research. Researchers and professionals seeking to stay abreast of the latest developments can benefit from its rigorous peer-reviewed articles and insightful reviews, which span a convergence of studies from 1997 to 2024. Although not an open-access journal, it provides ample opportunities for institutional subscriptions and ensures a global reach, facilitating the dissemination of vital scientific knowledge. The journal's impact is further underscored by its impressive Scopus rankings, reaffirming its importance as a key resource for scholars intent on advancing their understanding of nitric oxide's biological significance.

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.